Have a personal or library account? Click to login
Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis Cover

Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis

Open Access
|Sep 2025

Authors

Angelika Mańkowska

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland

Paulina Paprocka

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland

Grzegorz Król

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland

Agata Lesiak

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland

Jakub Spałek

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland
Department of Otolaryngology, Holy-Cross Oncology Center of Kielce, Head and Neck Surgery, Kielce, Poland

Ewelina Piktel

Independent Laboratory of Nanomedicine, Medical University of Białystok, Białystok, Poland

Sławomir Okła

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland
Department of Otolaryngology, Holy-Cross Oncology Center of Kielce, Head and Neck Surgery, Kielce, Poland

Piotr Bijak

Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland

Wiesława Niklińska

Department of Histology and Embryology, Medical University of Białystok, Białystok, Poland

Bonita Durnaś

Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland
Department of Clinical Microbiology, Holy-Cross Oncology Center of Kielce, Kielce, Poland

Robert Bucki

buckirobert@gmail.com

Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland
Language: English
Submitted on: Apr 17, 2025
|
Accepted on: Jun 7, 2025
|
Published on: Sep 7, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Angelika Mańkowska, Paulina Paprocka, Grzegorz Król, Agata Lesiak, Jakub Spałek, Ewelina Piktel, Sławomir Okła, Piotr Bijak, Wiesława Niklińska, Bonita Durnaś, Robert Bucki, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.